US Stock MarketDetailed Quotes

TXG 10x Genomics

Watchlist
  • 27.590
  • +0.690+2.57%
Close Apr 26 16:00 ET
  • 27.590
  • 0.0000.00%
Post 16:01 ET
3.29BMarket Cap-12655P/E (TTM)

10x Genomics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.78%-15.2M
87.70%25.76M
-164.58%-25.3M
32.05%-11.53M
80.17%-4.13M
-57.24%-33.61M
136.40%13.72M
63.52%-9.56M
-643.69%-16.96M
-409.60%-20.8M
Net income from continuing operations
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
Operating gains losses
--1.72M
--3K
--0
--0
--1.72M
----
----
----
----
----
Depreciation and amortization
32.15%43.62M
38.17%11.71M
40.73%11.42M
40.66%11.88M
8.04%8.62M
16.82%33.01M
15.67%8.47M
11.55%8.12M
17.49%8.44M
23.30%7.98M
Other non cash items
----
----
----
67.15%463K
-18.03%150K
----
----
----
--277K
--183K
Change In working capital
144.00%17.34M
188.22%17.07M
262.69%16.17M
-503.62%-9.93M
52.68%-5.96M
54.92%-39.42M
-93.70%-19.35M
76.49%-9.94M
112.32%2.46M
17.17%-12.59M
-Change in receivables
43.99%-10.61M
46.78%-10.97M
-119.87%-16.17M
-3,383.84%-9.75M
201.09%26.28M
44.34%-18.95M
-202.14%-20.62M
62.09%-7.35M
118.17%297K
241.02%8.73M
-Change in inventory
137.14%7.87M
632.08%7.61M
129.65%2.57M
74.72%-1.86M
87.98%-449K
29.67%-21.19M
83.71%-1.43M
-21.39%-8.66M
-31.49%-7.37M
56.63%-3.74M
-Change in prepaid assets
45.96%-2.43M
159.72%1.22M
-152.68%-1.52M
244.41%2.13M
-9.81%-4.25M
-326.88%-4.5M
-1,320.36%-2.04M
2,027.33%2.89M
-386.96%-1.48M
-144.51%-3.87M
-Change in payables and accrued expense
142.38%22.28M
6,406.94%15.94M
25.63%4.53M
-54.21%2.75M
-41.44%-942K
127.07%9.19M
-56.64%245K
115.67%3.61M
137.96%6.01M
-115.38%-666K
-Change in other current assets
-173.30%-678K
-175.49%-388K
5,907.77%17.78M
-18,002.38%-7.6M
-6,768.79%-10.47M
-11.48%925K
-26.26%514K
125.95%296K
-180.77%-42K
-4.85%157K
-Change in other current liabilities
21.12%-7.39M
-20.94%-2.17M
83.93%-923K
-34.19%-2.25M
-1,255.63%-2.05M
-30.54%-9.37M
-203.89%-1.8M
-738.33%-5.75M
33.64%-1.67M
96.96%-151K
-Change in other working capital
85.82%8.3M
0.78%5.83M
97.05%9.9M
-0.94%6.65M
-7.85%-14.08M
-75.02%4.46M
20.89%5.78M
-21.62%5.02M
33.41%6.71M
-891.09%-13.05M
Cash from discontinued investing activities
Operating cash flow
54.78%-15.2M
87.70%25.76M
-164.58%-25.3M
32.05%-11.53M
80.17%-4.13M
-57.24%-33.61M
136.40%13.72M
63.52%-9.56M
-643.69%-16.96M
-409.60%-20.8M
Investing cash flow
Cash flow from continuing investing activities
138.04%133.49M
139.49%13.1M
115.02%4.9M
83.79%-4.46M
146.57%119.96M
-228.76%-350.89M
-20.11%-33.17M
-61.32%-32.63M
-88.96%-27.53M
-481.19%-257.56M
Net PPE purchase and sale
63.09%-48.6M
91.32%-3.45M
58.34%-15.24M
6.84%-25.36M
83.80%-4.56M
-30.00%-131.66M
-43.87%-39.73M
-80.81%-36.57M
-86.84%-27.22M
27.61%-28.14M
Net intangibles purchase and sale
---923K
--0
---200K
--0
---723K
--0
--0
--0
--0
--0
Net business purchase and sale
--0
--0
----
----
----
26.62%-4M
---2.5M
----
----
----
Net investment purchase and sale
185.03%183.02M
82.61%16.55M
273.69%20.34M
6,883.77%20.89M
154.59%125.24M
---215.23M
--9.06M
--5.44M
---308K
---229.42M
Cash from discontinued investing activities
Investing cash flow
138.04%133.49M
139.49%13.1M
115.02%4.9M
83.79%-4.46M
146.57%119.96M
-228.76%-350.89M
-20.11%-33.17M
-61.32%-32.63M
-88.96%-27.53M
-481.19%-257.56M
Financing cash flow
Cash flow from continuing financing activities
-13.58%13.67M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-241.25%-3.41M
-55.19%15.82M
-43.83%5M
-69.49%2.04M
-60.72%6.36M
-31.30%2.42M
Proceeds from stock option exercised by employees
-8.21%19.48M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-69.33%2.4M
-47.36%21.23M
-43.83%5M
-69.49%2.04M
-60.72%6.36M
-8.42%7.83M
Net other financing activities
-7.49%-5.81M
--0
--0
--0
-7.49%-5.81M
-7.58%-5.41M
--0
--0
--0
-7.58%-5.41M
Cash from discontinued financing activities
Financing cash flow
-13.58%13.67M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-241.25%-3.41M
-55.19%15.82M
-43.83%5M
-69.49%2.04M
-60.72%6.36M
-31.30%2.42M
Net cash flow
Beginning cash position
-61.86%227.35M
30.30%314.74M
17.41%330.85M
6.15%339.79M
-61.86%227.35M
-13.44%596.07M
-60.34%241.55M
-56.56%281.79M
-50.29%320.11M
-13.44%596.07M
Current changes in cash
135.79%131.96M
407.79%44.47M
60.08%-16.03M
76.68%-8.89M
140.74%112.42M
-297.26%-368.68M
-11.91%-14.45M
-0.99%-40.16M
-903.58%-38.13M
-514.85%-275.94M
Effect of exchange rate changes
25.00%-33K
-69.32%77K
0.00%-85K
74.48%-49K
233.33%24K
-118.80%-44K
406.10%251K
-172.65%-85K
-3,300.00%-192K
-109.33%-18K
End cash Position
58.03%359.28M
58.03%359.28M
30.30%314.74M
17.41%330.85M
6.15%339.79M
-61.86%227.35M
-61.86%227.35M
-60.34%241.55M
-56.56%281.79M
-50.29%320.11M
Free cash flow
60.84%-64.72M
185.76%22.31M
11.70%-40.74M
16.52%-36.88M
80.78%-9.41M
-34.75%-165.27M
-19.25%-26.01M
0.66%-46.14M
-285.94%-44.18M
-13.95%-48.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.78%-15.2M87.70%25.76M-164.58%-25.3M32.05%-11.53M80.17%-4.13M-57.24%-33.61M136.40%13.72M63.52%-9.56M-643.69%-16.96M-409.60%-20.8M
Net income from continuing operations -53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M-144.10%-41.91M-483.22%-64.46M-267.18%-42.41M
Operating gains losses --1.72M--3K--0--0--1.72M--------------------
Depreciation and amortization 32.15%43.62M38.17%11.71M40.73%11.42M40.66%11.88M8.04%8.62M16.82%33.01M15.67%8.47M11.55%8.12M17.49%8.44M23.30%7.98M
Other non cash items ------------67.15%463K-18.03%150K--------------277K--183K
Change In working capital 144.00%17.34M188.22%17.07M262.69%16.17M-503.62%-9.93M52.68%-5.96M54.92%-39.42M-93.70%-19.35M76.49%-9.94M112.32%2.46M17.17%-12.59M
-Change in receivables 43.99%-10.61M46.78%-10.97M-119.87%-16.17M-3,383.84%-9.75M201.09%26.28M44.34%-18.95M-202.14%-20.62M62.09%-7.35M118.17%297K241.02%8.73M
-Change in inventory 137.14%7.87M632.08%7.61M129.65%2.57M74.72%-1.86M87.98%-449K29.67%-21.19M83.71%-1.43M-21.39%-8.66M-31.49%-7.37M56.63%-3.74M
-Change in prepaid assets 45.96%-2.43M159.72%1.22M-152.68%-1.52M244.41%2.13M-9.81%-4.25M-326.88%-4.5M-1,320.36%-2.04M2,027.33%2.89M-386.96%-1.48M-144.51%-3.87M
-Change in payables and accrued expense 142.38%22.28M6,406.94%15.94M25.63%4.53M-54.21%2.75M-41.44%-942K127.07%9.19M-56.64%245K115.67%3.61M137.96%6.01M-115.38%-666K
-Change in other current assets -173.30%-678K-175.49%-388K5,907.77%17.78M-18,002.38%-7.6M-6,768.79%-10.47M-11.48%925K-26.26%514K125.95%296K-180.77%-42K-4.85%157K
-Change in other current liabilities 21.12%-7.39M-20.94%-2.17M83.93%-923K-34.19%-2.25M-1,255.63%-2.05M-30.54%-9.37M-203.89%-1.8M-738.33%-5.75M33.64%-1.67M96.96%-151K
-Change in other working capital 85.82%8.3M0.78%5.83M97.05%9.9M-0.94%6.65M-7.85%-14.08M-75.02%4.46M20.89%5.78M-21.62%5.02M33.41%6.71M-891.09%-13.05M
Cash from discontinued investing activities
Operating cash flow 54.78%-15.2M87.70%25.76M-164.58%-25.3M32.05%-11.53M80.17%-4.13M-57.24%-33.61M136.40%13.72M63.52%-9.56M-643.69%-16.96M-409.60%-20.8M
Investing cash flow
Cash flow from continuing investing activities 138.04%133.49M139.49%13.1M115.02%4.9M83.79%-4.46M146.57%119.96M-228.76%-350.89M-20.11%-33.17M-61.32%-32.63M-88.96%-27.53M-481.19%-257.56M
Net PPE purchase and sale 63.09%-48.6M91.32%-3.45M58.34%-15.24M6.84%-25.36M83.80%-4.56M-30.00%-131.66M-43.87%-39.73M-80.81%-36.57M-86.84%-27.22M27.61%-28.14M
Net intangibles purchase and sale ---923K--0---200K--0---723K--0--0--0--0--0
Net business purchase and sale --0--0------------26.62%-4M---2.5M------------
Net investment purchase and sale 185.03%183.02M82.61%16.55M273.69%20.34M6,883.77%20.89M154.59%125.24M---215.23M--9.06M--5.44M---308K---229.42M
Cash from discontinued investing activities
Investing cash flow 138.04%133.49M139.49%13.1M115.02%4.9M83.79%-4.46M146.57%119.96M-228.76%-350.89M-20.11%-33.17M-61.32%-32.63M-88.96%-27.53M-481.19%-257.56M
Financing cash flow
Cash flow from continuing financing activities -13.58%13.67M12.24%5.61M114.52%4.37M11.57%7.1M-241.25%-3.41M-55.19%15.82M-43.83%5M-69.49%2.04M-60.72%6.36M-31.30%2.42M
Proceeds from stock option exercised by employees -8.21%19.48M12.24%5.61M114.52%4.37M11.57%7.1M-69.33%2.4M-47.36%21.23M-43.83%5M-69.49%2.04M-60.72%6.36M-8.42%7.83M
Net other financing activities -7.49%-5.81M--0--0--0-7.49%-5.81M-7.58%-5.41M--0--0--0-7.58%-5.41M
Cash from discontinued financing activities
Financing cash flow -13.58%13.67M12.24%5.61M114.52%4.37M11.57%7.1M-241.25%-3.41M-55.19%15.82M-43.83%5M-69.49%2.04M-60.72%6.36M-31.30%2.42M
Net cash flow
Beginning cash position -61.86%227.35M30.30%314.74M17.41%330.85M6.15%339.79M-61.86%227.35M-13.44%596.07M-60.34%241.55M-56.56%281.79M-50.29%320.11M-13.44%596.07M
Current changes in cash 135.79%131.96M407.79%44.47M60.08%-16.03M76.68%-8.89M140.74%112.42M-297.26%-368.68M-11.91%-14.45M-0.99%-40.16M-903.58%-38.13M-514.85%-275.94M
Effect of exchange rate changes 25.00%-33K-69.32%77K0.00%-85K74.48%-49K233.33%24K-118.80%-44K406.10%251K-172.65%-85K-3,300.00%-192K-109.33%-18K
End cash Position 58.03%359.28M58.03%359.28M30.30%314.74M17.41%330.85M6.15%339.79M-61.86%227.35M-61.86%227.35M-60.34%241.55M-56.56%281.79M-50.29%320.11M
Free cash flow 60.84%-64.72M185.76%22.31M11.70%-40.74M16.52%-36.88M80.78%-9.41M-34.75%-165.27M-19.25%-26.01M0.66%-46.14M-285.94%-44.18M-13.95%-48.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg